At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
Direct message the job poster from Philogen S.p.A. Philogen S.p.A. is a biotechnology company whose mission is the development of biologic products for the imaging and therapy of life‑threatening diseases, with a strategic focus on cancer
Overview In this role you will lead end-to-end delivery of industrial project logistics, from tender to close-out, steering planning, risk mitigation, and compliance. You will drive commercial management, client engagement, and cross-functional collaboration to ensure on-time,
Direct message the job poster from Philogen S.p.A. Philogen S.p.A. is a biotechnology company whose mission is the development of biologic products for the imaging and therapy of life‑threatening diseases, with a strategic focus on cancer
Overview In this role you will coordinate the operational management of assigned clinical trials to ensure timely, on-budget delivery compliant with ICH GCP and Chiesi SOPs. You will liaise with multiple stakeholders and manage study budgets and
Overview As Statistical Scientist Director, you will lead statistical strategy for complex client studies, guiding design through reporting. You will translate quantitative concepts for non-statistical stakeholders and oversee innovative analysis approaches. You’ll manage deliverables, risk mitigation, and
INTERNATIONAL RECRUITMENT & HR EXPERTS ACROSS THE PLASTICS, PACKAGING, SPECIALITY CHEMICALS, LIFE SCIENCES, BIOPOLYMER, FOOD ADDITIVES & INGREDIENTS, ENERGY AND RECYCLING SECTORS SINCE 1975. Sales Executive / Area Manager – Polymer Materials, Italy Job ref: AZ/65089 Client
An exciting oncology launch opportunity! Senior Medical Science Liaison Manager (F/M/X) Italy Our client is a pioneering oncology company developing innovative targeted therapies for patients with RAS-driven cancers, which account for approximately 30% of all cancer diagnoses